CS logo
small CS logo
Hospital de Salamanca

Salamanca, Spain
Hospital universitario en Salamanca

About Hospital de Salamanca


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hospital de Salamanca


During the past decade, Hospital de Salamanca conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital de Salamanca" #1 sponsor was "Daiichi Sankyo, Inc." with 1 trials, followed by "Dr. FRANCISCO J. BLANCO-GARCIA" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Salamanca" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Hospital de Salamanca


According to Clinical.Site data, the most researched conditions in "Hospital de Salamanca" are "Acute Myeloid Leukemia" (1 trials), "Early Alzheimer's Disease" (1 trials), "Leukemia" (1 trials), "Multiple Myeloma" (1 trials) and "Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Hospital de Salamanca" in a lesser frequency.

Clinical Trials Intervention Types at Hospital de Salamanca


Most popular intervention types in "Hospital de Salamanca" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Adalimumab (HUMIRA®)" (1 trials), "CC-220" (1 trials), "CC-99282" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital de Salamanca


The vast majority of trials in "Hospital de Salamanca" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Hospital de Salamanca


Currently, there are NaN active trials in "Hospital de Salamanca". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital de Salamanca, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Salamanca, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".